全球藥物濫用測試市場規模、佔有率、成長分析（按藥物、按樣本）- 2024-2031 年產業預測

Global Drug of Abuse Testing Market Size, Share, Growth Analysis, By Drug(Alcohol, Cocaine), By Sample(Urine, Saliva) - Industry Forecast 2024-2031

出版日期: 2024年03月05日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球濫用藥物檢測市場規模將為67億美元，預測期間（2024-2031年）複合年成長率為6.3%，從2023年的71.2億美元成長至116.1億美元。

由於藥物濫用現像日益普遍、行業中對藥物檢測的嚴格監管以及人們對醫療保健和職場環境中藥物檢測重要性的認知不斷提高等因素，全球藥物濫用檢測市場正在顯著成長。該市場是由對檢測和預防藥物濫用的藥物檢測服務不斷成長的需求推動的，根據聯合國毒品犯罪防制署的《世界毒品報告》，該市場約有 2.55 億使用者。事實確實如此。政府提高藥物檢測意識和組織合規性的措施也有助於市場擴張。然而，也存在一些挑戰，例如測試產品無法準確檢測少量的某些藥物，以及偏好和非法藥物使用合法化的法律變化對市場需求的影響。儘管面臨挑戰，免疫檢測、層析法和分子診斷等測試技術的進步提高了測試的靈敏度、特異性和準確性，為市場提供了成長機會。藥物檢測與其他醫療保健服務的整合以及口腔液檢測需求的增加也進一步推動了市場的成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭形勢

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Abbott Laboratories（US）
Thermo Fisher Scientific Inc.（US）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Alere Inc.（US）
Quest Diagnostics Incorporated（US）
Bio-Rad Laboratories, Inc.（US）
Dragerwerk AG & Co. KGaA（Germany）
Biomerieux SA（France）
Shimadzu Corporation（Japan）
Randox Laboratories Ltd.（United Kingdom）
Psychemedics Corporation（US）
Sonic Healthcare（Australia）
Merck KGaA（Germany）
LabCorp（US）
MP Biomedicals LLC（US）
Omega Laboratories, Inc.（US）
Express Diagnostics International Inc.（US）
Sciteck, Inc.（US）
Premier Biotech Inc.（US）

簡介目錄

Product Code: SQMIG30A2015

Global Drug of Abuse Testing Market size was valued at USD 6.7 Billion in 2022 and is poised to grow from USD 7.12 Billion in 2023 to USD 11.61 Billion by 2031, at a CAGR of 6.3% during the forecast period (2024- 2031).

The global drug of abuse testing market is witnessing significant growth driven by factors such as the increasing prevalence of substance abuse, stringent regulations for drug testing in industries, and growing awareness about drug testing's importance in healthcare and workplace settings. The market is propelled by rising demand for drug testing services to detect and prevent substance abuse, with approximately 255 million users reported in the World Drug Report by the United Nations Office on Drugs and Crime. Government initiatives promoting awareness and organizational compliance for drug testing also contribute to market expansion. However, challenges include the inability of testing products to detect small amounts of certain drugs accurately and the impact of changing laws legalizing recreational or illicit drug use on market demand. Despite challenges, the market offers growth opportunities driven by technological advancements in testing technologies like immunoassays, chromatography, and molecular diagnostics, enhancing testing sensitivity, specificity, and accuracy. Integration of drug testing with other healthcare services and increasing demand for oral fluid testing further drive market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug of Abuse Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug of Abuse Testing Market Segmental Analysis

The global drug abuse testing market is segmented on the basis of drug, sample, and region. By drug, the market is segmented into alcohol, cocaine, marijuana/cannabis, LSD, opioids, and others. By sample, the market is segmented into Urine, Saliva, Blood, Hair, Breath, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Drug of Abuse Testing Market

The growing production, consumption, and trade of both new and illicit drugs are expected to drive the demand for Drug of Abuse (DoA) testing, thus fueling the industry's growth. According to the United Nations Office on Drugs and Crime's World Drug Report 2017, there was an annual prevalence of 5.3% for illicit drug use, with 255 million users in 2015. This significant number of drug users underscores the necessity for DoA testing, which will propel the market forward. Government initiatives aimed at raising awareness about drug abuse and increasing organizational compliance for DoA testing will also contribute to the overall growth of the market. Additionally, there is a high demand for testing products that offer enhanced specificity and sensitivity to detect designer drugs, further bolstering the industry's expansion.

Restraints in the Global Drug of Abuse Testing Market

The growth of the drugs of abuse (DOA) testing market may face restraints due to limitations in current testing products detecting small amounts of specific drugs. Additionally, the transformation of laws to legalize recreational or illicit drugs is expected to pose a challenge during the forecast period of 2024-2031. This report on the DOA testing market provides comprehensive information on recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and local market players, emerging revenue opportunities, changes in market regulations, strategic growth analysis, market size, category market growth, application niches, product approvals, product launches, geographic expansions, and technological innovations. For more detailed information on the DOA testing market, you can contact Data Bridge Market Research for an Analyst Brief, where their team will assist you in making informed decisions to achieve market growth.

Market Trends of the Global Drug of Abuse Testing Market

There is a growing trend towards point-of-care testing, which enables quick and convenient drug testing at the bedside or in non-laboratory settings. This trend is fueled by the demand for rapid results and the capability to perform tests in remote or decentralized locations.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Drug of Abuse Testing Market by Drug

Market Overview
Alcohol
Cocaine
Marijuana/Cannabis
LSD
Opioids
and Others.

Global Drug of Abuse Testing Market by Sample

Market Overview
Urine
Saliva
Blood
Hair
Breath
and Others

Global Drug of Abuse Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabCorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MP Biomedicals LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Express Diagnostics International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Premier Biotech Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments